Scholarly Works per year
Scholarly Works per year
Fingerprint
Dive into the research topics where Thomas P Miller is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
ALK-negative anaplastic large cell lymphoma: Features and outcomes of 235 patients from the International T-Cell Project
on behalf of the T-cell Lymphoma Project, Feb 9 2021, In: Blood Advances. 5, 3Research output: Contribution to journal › Article › peer-review
Open Access19 Scopus citations -
Positron emission tomography-directed therapy for patients with limited-stage diffuse large B-cell lymphoma: Results of intergroup national clinical trials network study S1001
Persky, D. O., Li, H., Stephens, D. M., Park, S. I., Bartlett, N. L., Swinnen, L. J., Barr, P. M., Winegarden, J. D., Constine, L. S., Fitzgerald, T. J., Leonard, J. P., Kahl, B. S., LeBlanc, M. L., Song, J. Y., Fisher, R. I., Rimsza, L. M., Smith, S. M., Miller, T. P. & Friedberg, J. W., Sep 10 2020, In: Journal of Clinical Oncology. 38, 26, p. 3003-3011 9 p.Research output: Contribution to journal › Article › peer-review
61 Scopus citations -
A phase II study of belinostat (PXD101) in relapsed and refractory aggressive B-cell lymphomas: SWOG S0520
Puvvada, S. D., Li, H., Rimsza, L. M., Bernstein, S. H., Fisher, R. I., LeBlanc, M., Schmelz, M., Glinsmann-Gibson, B., Miller, T. P., Maddox, A. M., Friedberg, J. W., Smith, S. M. & Persky, D. O., Oct 2 2016, In: Leukemia and Lymphoma. 57, 10, p. 2359-2369 11 p.Research output: Contribution to journal › Article › peer-review
33 Scopus citations -
Phase I study of single-agent CC-292, a highly selective bruton’s tyrosine kinase inhibitor, in relapsed/refractory chronic lymphocytic leukemia
Brown, J. R., Harb, W. A., Hill, B. T., Gabrilove, J., Sharman, J. P., Schreeder, M. T., Barr, P. M., Foran, J. M., Miller, T. P., Burger, J. A., Kelly, K. R., Mahadevan, D., Ma, S., Li, Y., Pierce, D. W., Barnett, E., Marine, J., Miranda, M., Azaryan, A., Yu, X., & 3 others, 2016, In: Haematologica. 101, 7, p. e295-e298Research output: Contribution to journal › Letter › peer-review
Open Access54 Scopus citations -
Ibritumomab consolidation after 3 cycles of CHOP plus radiotherapy in high-risk limited-stage aggressive B-cell lymphoma: SWOG S0313
Persky, D. O., Miller, T. P., Unger, J. M., Spier, C. M., Puvvada, S. D., Dino Stea, B., Press, O. W., Constine, L. S., Barton, K. P., Friedberg, J. W., LeBlanc, M. & Fisher, R. I., Aug 8 2015, In: Blood. 125, 2, p. 236-241 6 p.Research output: Contribution to journal › Article › peer-review
15 Scopus citations
-
Therapeutic Targeting of Hypoxic and Oxidative Stress
Landowski, T. H., Miller, T. P., Landowski, T. H., Hersh, E. M., Roe, D. & Roe, D.
Project: Research project
-
-
University of Arizona Cancer Center - Cancer Center Support Grant [MICEO Administrative Supplement]
Bhattacharyya, A. K., Briehl, M. M., Cress, A. E., Doetschman, T. C., Ellis, N., Futscher, B. W., Garland, L. L., Hersh, E. M., Ignatenko, N., Livingston, R. B., Miesfeld, R. L., Miranti, C., Nagle, R. B., Stratton, S. P., Tsaprailis, G., Watts, G. S., Dorr, R. T., Weinstein, R. S., Mash, E. A., Montfort, W. R., Warfel, N. A., Roe, D., Miller, T. P., Gelmann, E. P., Hurley, L., Sweasy, J., Davis, T. P., Kraft, A. & Lynch, R. M.
Project: Research project
-
-
CORE--CLINICAL CANCER RESEARCH PROGRAM
Miller, T. P., Miranti, C. & Miranti, C.
Project: Research project